Luxury carmaker Audi has initiated its plan to give stiff competition to Tesla (TSLA) with the start of production of the most-anticipated all-electric “e-tron Quattro SUV” at its Brussels factory. This is just two weeks ahead of the vehicle’s planned debut on September 17 this year.
It is expected that people could buy the vehicle in early 2019 with the launch being scheduled by the automaker at the end of this year. The company will accept reservations for the vehicle in the US on the same debut date with an initial $1,000 deposit, and it can be configured at Audi’s website on the same day.
The e-tron SUV is Audi’s first of the three vehicles coming in the next two years, and this could establish the company in the all-electric vehicle space. Audi hasn’t decided on the capacity of the annual production of the vehicles.
The e-tron – a 5-passenger premium SUV – has a 245 miles range and takes about 8.5 hours to charge with the standard home charger that will deliver 11kW. The full technical specifications can be expected at the event.
The company has been experiencing a delay in the launch due to diesel emission scandal that led to CEO Rupert Stadler’s arrest on June 18. Volkswagen, the parent company of Audi, named Bram Schot as Interim CEO, replacing Stadler. Stadler will remain at a prison in the Bavarian city of Augsburg after the rejection of an appeal.
Related: Audi CEO behind bars due to dieselgate emission scandal
Stadler was arrested over allegations that he attempted to tamper with evidence relating to a scandal. The court alleges that Stadler had knowledge of emission-software manipulation and he allowed cars fitted with such so-called “defeat devices” to still be sold. About 11 million Volkswagen cars were fitted with defeat devices that bypassed the emissions tests.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
Comments
Comments are closed.